Rely on us for your high-quality sterile injectable manufacturing
Hikma provides extensive capabilities for manufacturing sterile injectable products, including vials (liquid and lyophilised), prefilled syringes, infusion bags, and ampoules for aqueous, oil-based, suspension, or emulsion forms.
With an installed capacity of over 500 million units, expansion is underway in both the EU and the US.
Excellent Quality RecordUS FDA | EMA | Japan FDA | Jordan FDA | Korea | GCC | ANVISA
Integrated servicesDevelopment phase | Scale-up processes | Fill and finish
Distribution50+ markets
Our operations
Our largest centre of excellence for injectable manufacturing offers diverse capabilities, including lyophilisation, high containment, liquid lines, IV bags, and cephalosporins. Fifty per cent of its injectable production is dedicated to the US market. It also services Europe and MENA.
Our liquid and lyophilisation cytotoxic hub for the US, Europe and MENA.
Our lyophilisation hub for Europe and MENA.
Our controlled substances and prefilled syringe manufacturing hub for the US.
Our newest site for septic bags filling and lyophilisation for the US.
High-quality prefilled manufacturing operations in the US
Get in touch
Contact us to discuss your Injectables CMO needs and book a tour in our facilities
